These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 1391596

  • 1. Non-receptor muscle antibodies in myasthenia gravis are of IgG1 and IgG4 subclasses.
    Hofstad H, Gilhus NE, Matre R, Aarli JA.
    Autoimmunity; 1992; 12(4):271-6. PubMed ID: 1391596
    [Abstract] [Full Text] [Related]

  • 2. A triple antibody assay for the quantitation of plasma IgG subclass antibodies to acetylcholine receptors in patients with myasthenia gravis.
    Nielsen FC, Rødgaard A, Djurup R, Somnier F, Gammeltoft S.
    J Immunol Methods; 1985 Nov 07; 83(2):249-58. PubMed ID: 3902978
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of serum IgG subclass concentrations in myasthenia gravis patients.
    Liu Y, Wang W, Li J.
    Int J Neurosci; 2011 Oct 07; 121(10):570-4. PubMed ID: 21770714
    [Abstract] [Full Text] [Related]

  • 4. Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3.
    Rødgaard A, Nielsen FC, Djurup R, Somnier F, Gammeltoft S.
    Clin Exp Immunol; 1987 Jan 07; 67(1):82-8. PubMed ID: 3621677
    [Abstract] [Full Text] [Related]

  • 5. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.
    Mygland A, Tysnes OB, Aarli JA, Matre R, Gilhus NE.
    J Autoimmun; 1993 Aug 07; 6(4):507-15. PubMed ID: 8216692
    [Abstract] [Full Text] [Related]

  • 6. IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies.
    Smith CI, Aarli JA, Hammarström L, Persson MA.
    Neurology; 1984 Aug 07; 34(8):1094-6. PubMed ID: 6540388
    [Abstract] [Full Text] [Related]

  • 7. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review.
    Huang GZ, Lo YL.
    J Clin Neuromuscul Dis; 2013 Jun 07; 14(4):209-17. PubMed ID: 23703018
    [Abstract] [Full Text] [Related]

  • 8. Myasthenia gravis: the specificities of skeletal muscle and thymus antibodies.
    Gilhus NE, Aarli JA, Matre R.
    Acta Neurol Scand; 1983 Nov 07; 68(5):328-36. PubMed ID: 6364682
    [Abstract] [Full Text] [Related]

  • 9. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
    Zisimopoulou P, Evangelakou P, Tzartos J, Lazaridis K, Zouvelou V, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Frenkian Cuvelier M, Stojkovic T, DeBaets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B, Lavrnic D, Basta I, Peric S, Tallaksen C, Maniaol A, Tzartos SJ.
    J Autoimmun; 2014 Aug 07; 52():139-45. PubMed ID: 24373505
    [Abstract] [Full Text] [Related]

  • 10. Myasthenia gravis muscle antibodies examined by ELISA: IgG and IgM antibodies characterize different patient subgroups.
    Hofstad H, Ulvestad E, Gilhus NE, Matre R, Aarli JA.
    Acta Neurol Scand; 1992 Apr 07; 85(4):233-8. PubMed ID: 1585794
    [Abstract] [Full Text] [Related]

  • 11. Skeletal muscle antibodies in patients with a thymic tumour but without myasthenia gravis.
    Gilhus NE, Aarli JA, Janzen RW, Otto HF, Fasske E, Matre R.
    J Neuroimmunol; 1985 May 07; 8(2-3):69-78. PubMed ID: 3998123
    [Abstract] [Full Text] [Related]

  • 12. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
    Ohta M, Itoh M, Hara H, Itoh N, Nishitani H, Hayashi K, Ohta K.
    Clin Chim Acta; 1991 Sep 30; 201(3):201-5. PubMed ID: 1756593
    [Abstract] [Full Text] [Related]

  • 13. Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1.
    Niks EH, van Leeuwen Y, Leite MI, Dekker FW, Wintzen AR, Wirtz PW, Vincent A, van Tol MJ, Jol-van der Zijde CM, Verschuuren JJ.
    J Neuroimmunol; 2008 Mar 30; 195(1-2):151-6. PubMed ID: 18384886
    [Abstract] [Full Text] [Related]

  • 14. Heart muscle antibodies in myasthenia gravis.
    Mygland A, Aarli JA, Hofstad H, Gilhus NE.
    Autoimmunity; 1991 Mar 30; 10(4):263-7. PubMed ID: 1772962
    [Abstract] [Full Text] [Related]

  • 15. Seronegative generalized myasthenia gravis: low frequency of thymic pathology.
    Verma PK, Oger JJ.
    Neurology; 1992 Mar 30; 42(3 Pt 1):586-9. PubMed ID: 1296581
    [Abstract] [Full Text] [Related]

  • 16. The immunopathology of myasthenia gravis.
    Lennon VA.
    Hum Pathol; 1978 Sep 30; 9(5):541-51. PubMed ID: 309428
    [Abstract] [Full Text] [Related]

  • 17. Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies.
    Verschuuren JJGM, Plomp JJ, Burden SJ, Zhang W, Fillié-Grijpma YE, Stienstra-van Es IE, Niks EH, Losen M, van der Maarel SM, Huijbers MG.
    Ann N Y Acad Sci; 2018 Feb 30; 1413(1):111-118. PubMed ID: 29356029
    [Abstract] [Full Text] [Related]

  • 18. Penicillamine-associated myasthenia gravis, antiacetylcholine receptor and antistriational antibodies.
    Masters CL, Dawkins RL, Zilko PJ, Simpson JA, Leedman RJ.
    Am J Med; 1977 Nov 30; 63(5):689-94. PubMed ID: 930944
    [Abstract] [Full Text] [Related]

  • 19. [Diagnosis of thymoma and thymic atrophy in patients with myasthenia gravis].
    Sund KK, Skeie GO, Gilhus NE, Aarli JA, Varhaug JE.
    Tidsskr Nor Laegeforen; 1997 Nov 30; 117(29):4212-4. PubMed ID: 9441462
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.